» Articles » PMID: 29572634

Non-invasive Radiomics Approach Potentially Predicts Non-functioning Pituitary Adenomas Subtypes Before Surgery

Overview
Journal Eur Radiol
Specialty Radiology
Date 2018 Mar 25
PMID 29572634
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To make individualised preoperative prediction of non-functioning pituitary adenoma (NFPAs) subtypes between null cell adenomas (NCAs) and other subtypes using a radiomics approach.

Methods: We enrolled 112 patients (training set: n = 75; test set: n = 37) with complete T1-weighted magnetic resonance imaging (MRI) and contrast-enhanced T1-weighted MRI (CE-T1). A total of 1482 quantitative imaging features were extracted from T1 and CE-T1 images. Support vector machine trained a predictive model that was validated using a receiver operating characteristics (ROC) analysis on an independent test set. Moreover, a nomogram was constructed incorporating clinical characteristics and the radiomics signature for individual prediction.

Results: T1 image features yielded area under the curve (AUC) values of 0.8314 and 0.8042 for the training and test sets, respectively, while CE-T1 image features provided no additional contribution to the predictive model. The nomogram incorporating sex and the T1 radiomics signature yielded good calibration in the training and test sets (concordance index (CI) = 0.854 and 0.857, respectively).

Conclusion: This study focused on the preoperative prediction of NFPA subtypes between NCAs and others using a radiomics approach. The developed model yielded good performance, indicating that radiomics had good potential for the preoperative diagnosis of NFPAs.

Key Points: • MRI may help in the pre-operative diagnosis of NFPAs subtypes • Retrospective study showed T1-weighted MRI more useful than CE-T1 in NCAs diagnosis • Treatment decision making becomes more individualised • Radiomics approach had potential for classification of NFPAs.

Citing Articles

Rathke's cleft cyst: From history to molecular genetics.

Hacioglu A, Tekiner H, Altinoz M, Ekinci G, Bonneville J, Yaltirik K Rev Endocr Metab Disord. 2025; .

PMID: 39939491 DOI: 10.1007/s11154-025-09949-6.


Preoperatively Predicting PIT1 Expression in Pituitary Adenomas Using Habitat, Intra-tumoral and Peri-tumoral Radiomics Based on MRI.

Zang Y, Zheng F, Feng L, Shi X, Chen X J Imaging Inform Med. 2025; .

PMID: 39904941 DOI: 10.1007/s10278-024-01376-4.


Differentiating Cystic Lesions in the Sellar Region of the Brain Using Artificial Intelligence and Machine Learning for Early Diagnosis: A Prospective Review of the Novel Diagnostic Modalities.

Patel K, Sanghvi H, Gill G, Agarwal O, Pandya A, Agarwal A Cureus. 2025; 16(12):e75476.

PMID: 39791061 PMC: 11717160. DOI: 10.7759/cureus.75476.


The current state of MRI-based radiomics in pituitary adenoma: promising but challenging.

Zheng B, Zhao Z, Zheng P, Liu Q, Li S, Jiang X Front Endocrinol (Lausanne). 2024; 15:1426781.

PMID: 39371931 PMC: 11449739. DOI: 10.3389/fendo.2024.1426781.


Radiomics of pituitary adenoma using computer vision: a review.

Zilka T, Benesova W Med Biol Eng Comput. 2024; 62(12):3581-3597.

PMID: 39012416 PMC: 11568991. DOI: 10.1007/s11517-024-03163-3.


References
1.
Kanner A, Corn B, Greenman Y . Radiotherapy of nonfunctioning and gonadotroph adenomas. Pituitary. 2008; 12(1):15-22. DOI: 10.1007/s11102-008-0089-3. View

2.
Nie K, Shi L, Chen Q, Hu X, Jabbour S, Yue N . Rectal Cancer: Assessment of Neoadjuvant Chemoradiation Outcome based on Radiomics of Multiparametric MRI. Clin Cancer Res. 2016; 22(21):5256-5264. PMC: 10916000. DOI: 10.1158/1078-0432.CCR-15-2997. View

3.
Balogun J, Monsalves E, Juraschka K, Parvez K, Kucharczyk W, Mete O . Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics. Endocr Pathol. 2014; 26(1):63-70. DOI: 10.1007/s12022-014-9347-2. View

4.
Fernandez A, Karavitaki N, Wass J . Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf). 2009; 72(3):377-82. DOI: 10.1111/j.1365-2265.2009.03667.x. View

5.
Wu J, Aguilera T, Shultz D, Gudur M, Rubin D, Loo Jr B . Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis. Radiology. 2016; 281(1):270-8. PMC: 5047129. DOI: 10.1148/radiol.2016151829. View